Feedback / Questions
AFNT-211 - Affini-T Therap
https://www.businesswire.com/news/home/20240528503183/en/Affini-T-Therapeutics-Announces-First-Patient-Dosed-in-KRAS-G12V-Phase-1-Program-and-Presentation-of-Trial-in-Progress-Poster-at-the-American-Society-of-Clinical-Oncology-ASCO-2024-Annual-Meeting
May 28, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next